|
Verona Pharma Sponsored Ads
(VRNA)
|
7.9 |
$58M |
|
610k |
94.58 |
|
Insmed Com Par $.01
(INSM)
|
6.5 |
$48M |
|
475k |
100.64 |
|
Xenon Pharmaceuticals
(XENE)
|
4.7 |
$34M |
|
1.1M |
31.30 |
|
Arcellx Common Stock
(ACLX)
|
4.5 |
$33M |
|
495k |
65.85 |
|
Blueprint Medicines
(BPMC)
|
4.4 |
$32M |
|
250k |
128.18 |
|
Nuvalent Inc-a
(NUVL)
|
4.3 |
$32M |
|
415k |
76.30 |
|
Apogee Therapeutics
(APGE)
|
4.1 |
$30M |
|
694k |
43.43 |
|
Alkermes SHS
(ALKS)
|
3.9 |
$29M |
|
1.0M |
28.61 |
|
Exelixis Put Option
(EXEL)
|
3.6 |
$26M |
|
600k |
44.08 |
|
Protagonist Therapeutics
(PTGX)
|
3.3 |
$24M |
|
440k |
55.27 |
|
Madrigal Pharmaceuticals
(MDGL)
|
3.3 |
$24M |
|
80k |
302.64 |
|
Teva Pharmaceutical Inds Sponsored Ads
(TEVA)
|
3.2 |
$24M |
|
1.4M |
16.76 |
|
Lexeo Therapeutics
(LXEO)
|
2.0 |
$14M |
|
3.6M |
4.02 |
|
Travere Therapeutics
(TVTX)
|
2.0 |
$14M |
|
970k |
14.80 |
|
Establishment Labs Holdings Ord
(ESTA)
|
2.0 |
$14M |
|
335k |
42.71 |
|
Trevi Therapeutics
(TRVI)
|
1.9 |
$14M |
|
2.5M |
5.47 |
|
Wave Life Sciences SHS
(WVE)
|
1.8 |
$13M |
|
2.0M |
6.50 |
|
Vera Therapeutics Cl A
(VERA)
|
1.8 |
$13M |
|
545k |
23.56 |
|
Mineralys Therapeutics
(MLYS)
|
1.7 |
$12M |
|
900k |
13.53 |
|
Centessa Pharmaceuticals Sponsored Ads
(CNTA)
|
1.6 |
$12M |
|
900k |
13.14 |
|
Karyopharm Therapeutics Note 3.000%10/1 (Principal)
|
1.6 |
$12M |
|
15M |
0.76 |
|
Amgen Call Option
(AMGN)
|
1.5 |
$11M |
|
40k |
279.21 |
|
Nurix Therapeutics
(NRIX)
|
1.5 |
$11M |
|
968k |
11.39 |
|
Rezolute Com New
(RZLT)
|
1.3 |
$9.8M |
|
2.2M |
4.46 |
|
Crispr Therapeutics Call Option
(CRSP)
|
1.3 |
$9.7M |
|
200k |
48.64 |
|
Ventyx Biosciences
(VTYX)
|
1.3 |
$9.7M |
|
4.5M |
2.14 |
|
Spyre Therapeutics Com New
(SYRE)
|
1.2 |
$9.1M |
|
607k |
14.97 |
|
Enliven Therapeutics
(ELVN)
|
1.1 |
$8.0M |
|
400k |
20.06 |
|
Proqr Thrapeutics N V Shs Euro
(PRQR)
|
1.0 |
$7.1M |
|
3.5M |
2.04 |
|
Akebia Therapeutics
(AKBA)
|
1.0 |
$7.1M |
|
2.0M |
3.64 |
|
Omeros Corp Note 9.500% 6/1 (Principal)
|
1.0 |
$7.1M |
|
9.0M |
0.78 |
|
Inozyme Pharma
(INZY)
|
1.0 |
$7.0M |
|
1.7M |
4.00 |
|
Autolus Therapeutics Spon Ads
(AUTL)
|
0.9 |
$6.9M |
|
3.0M |
2.28 |
|
Oruka Therapeutics
(ORKA)
|
0.9 |
$6.8M |
|
604k |
11.21 |
|
Travere Therapeutics Note 2.250% 3/0 (Principal)
|
0.9 |
$6.7M |
|
7.0M |
0.95 |
|
Bridgebio Pharma
(BBIO)
|
0.9 |
$6.5M |
|
150k |
43.18 |
|
Miragen Therapeutics
(VRDN)
|
0.7 |
$5.5M |
|
390k |
13.98 |
|
Axsome Therapeutics
(AXSM)
|
0.7 |
$5.2M |
|
50k |
104.39 |
|
Erasca
(ERAS)
|
0.7 |
$5.2M |
|
4.1M |
1.27 |
|
Newamsterdam Pharma Company Ordinary Shares
(NAMS)
|
0.7 |
$5.0M |
|
275k |
18.11 |
|
Crescent Biopharma
(CBIO)
|
0.6 |
$4.5M |
|
280k |
16.14 |
|
Roivant Sciences SHS
(ROIV)
|
0.6 |
$4.5M |
|
400k |
11.27 |
|
Crinetics Pharmaceuticals In
(CRNX)
|
0.6 |
$4.4M |
|
152k |
28.76 |
|
Vaxcyte
(PCVX)
|
0.6 |
$4.1M |
|
125k |
32.51 |
|
Perceptive Cap Solutions Cor Cl A Ord Shs
(PCSC)
|
0.5 |
$3.7M |
|
350k |
10.61 |
|
Merus N V
(MRUS)
|
0.5 |
$3.7M |
|
70k |
52.60 |
|
Perspective Therapeutics Com New
(CATX)
|
0.5 |
$3.6M |
|
1.1M |
3.44 |
|
Uniqure Nv SHS
(QURE)
|
0.4 |
$3.3M |
|
235k |
13.94 |
|
Avalo Therapeutics Com New
(AVTX)
|
0.4 |
$3.0M |
|
608k |
4.99 |
|
Oaktree Acquisition Corp Iii Unit 10/04/2029
(OACCU)
|
0.4 |
$2.7M |
|
250k |
10.62 |
|
Jazz Pharmaceuticals Shs Usd
(JAZZ)
|
0.4 |
$2.7M |
|
25k |
106.12 |
|
Monopar Therapeutics Com New
(MNPR)
|
0.3 |
$2.4M |
|
68k |
35.78 |
|
Rapport Therapeutics
(RAPP)
|
0.3 |
$2.3M |
|
200k |
11.37 |
|
Geron Corporation
(GERN)
|
0.3 |
$2.1M |
|
1.5M |
1.41 |
|
Third Harmonic Bio
(THRD)
|
0.3 |
$2.0M |
|
370k |
5.43 |
|
Cullinan Oncology
(CGEM)
|
0.3 |
$2.0M |
|
264k |
7.53 |
|
Newamsterdam Pharma Company *w Exp 99/99/999
(NAMSW)
|
0.3 |
$2.0M |
|
245k |
8.00 |
|
Eliem Therapeutics
(CLYM)
|
0.3 |
$1.9M |
|
1.5M |
1.24 |
|
Capricor Therapeutics Com New Put Option
(CAPR)
|
0.2 |
$1.7M |
|
175k |
9.93 |
|
Anteris Technologies Global
(AVR)
|
0.2 |
$1.6M |
|
425k |
3.79 |
|
Astria Therapeutics
(ATXS)
|
0.2 |
$1.6M |
|
300k |
5.36 |
|
Novavax Com New Call Option
(NVAX)
|
0.2 |
$1.6M |
|
250k |
6.30 |
|
Nkarta
(NKTX)
|
0.2 |
$1.3M |
|
800k |
1.66 |
|
Mirum Pharmaceuticals
(MIRM)
|
0.2 |
$1.3M |
|
25k |
50.89 |
|
Savara
(SVRA)
|
0.2 |
$1.1M |
|
500k |
2.28 |
|
Olema Pharmaceuticals
(OLMA)
|
0.1 |
$1.1M |
|
250k |
4.26 |
|
Nextcure
(NXTC)
|
0.1 |
$1.1M |
|
2.3M |
0.46 |
|
Omeros Corporation Put Option
(OMER)
|
0.1 |
$942k |
|
314k |
3.00 |
|
Onkure Therapeutics Com Cl A
(OKUR)
|
0.1 |
$832k |
|
348k |
2.39 |
|
Inmune Bio Ord Put Option
(INMB)
|
0.1 |
$818k |
|
354k |
2.31 |
|
Altimmune Com New Call Option
(ALT)
|
0.1 |
$774k |
|
200k |
3.87 |
|
Abivax Sa Sponsored Ads
(ABVX)
|
0.1 |
$765k |
|
100k |
7.65 |
|
Karyopharm Therapeutics Com New Call Option
(KPTI)
|
0.1 |
$679k |
|
158k |
4.31 |
|
Jade Biosciences Com New
(JBIO)
|
0.1 |
$653k |
|
65k |
9.99 |
|
Sutro Biopharma
(STRO)
|
0.1 |
$537k |
|
753k |
0.71 |
|
Galectin Therapeutics Com New Put Option
(GALT)
|
0.1 |
$528k |
|
250k |
2.11 |
|
Taysha Gene Therapies Com Shs
(TSHA)
|
0.1 |
$462k |
|
200k |
2.31 |
|
Context Therapeutics
(CNTX)
|
0.0 |
$339k |
|
518k |
0.66 |
|
Engene Holdings
(ENGN)
|
0.0 |
$280k |
|
77k |
3.64 |
|
Repare Therapeutics Ord
(RPTX)
|
0.0 |
$278k |
|
200k |
1.39 |
|
Zura Bio Class A Ord Shs
(ZURA)
|
0.0 |
$235k |
|
223k |
1.05 |
|
Ovid Therapeutics
(OVID)
|
0.0 |
$220k |
|
668k |
0.33 |
|
Radiopharm Theranostics Sponsored Ads
(RADX)
|
0.0 |
$166k |
|
36k |
4.66 |
|
Adagio Med Hldgs
(ADGM)
|
0.0 |
$108k |
|
80k |
1.35 |
|
Q32 Bio
(QTTB)
|
0.0 |
$41k |
|
28k |
1.49 |
|
Arbutus Biopharma Call Option
(ABUS)
|
0.0 |
$29k |
|
9.3k |
3.09 |
|
Rocket Pharmaceuticals *w Exp 09/02/202
(RCKTW)
|
0.0 |
$2.2k |
|
75k |
0.03 |
|
Immatics *w Exp 07/01/202
(IMTXW)
|
0.0 |
$112.322400 |
|
187k |
0.00 |